Inhibikase Therapeutics Inc (IKT) stock forecast: Can it reach its 52-week high of $3.82
A share price of Inhibikase Therapeutics Inc [IKT] is currently trading at $1.47, up 13.08%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IKT shares have gain 16.67% over the last week, with a monthly amount glided 22.50%, and seem to […]